Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Frostman who wrote (11137)	7/10/1998 11:09:00 AM
From: Mkilloran	Read Replies (1) \| Respond to of 23519

frostman....all Vivus has to do is rampup the new plant quickly...get international sales to the point that it sells all that they can make..... With the new plant (8) lines at max and old plant combined that sounds like close to 9 mill units a qtr....how fast they can ramp up and get to 8 lines is important. And what lessons did they lean with the new factory that can help speedup the construction and approval of the future plant in Ireland. Reduced cost and with the help of a US sales partner will get the profits and the stock will rise. R&D will set the stage for yr 2000 and beyond.....